Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Senator Rand Paul criticizes Trump's plan to use the military for mass deportations of illegal immigrants, calling it a 'terrible image' and a 'huge mistake'.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Senator Rand Paul criticizes Trump's plan to use the military for mass deportations of illegal immigrants, calling it a 'terrible image' and a 'huge mistake'.